Filing excerpt
On April 27, 2026, Quest Diagnostics Incorporated (the “Company”) issued a press release announcing the pricing of a public offering of $500 million aggregate principal amount of its 5.000% senior notes due 2036 (the “Notes”)
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-8kmaterialContractGet every 8-K signal for Quest Diagnostics and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Quest Diagnostics this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/8cb83a60-6091-4f54-9f14-d918db2f1f45 returns this record as JSON. POST /v1/companies/enrich returns every signal for questdiagnostics.com.
{
"signal_id": "8cb83a60-6091-4f54-9f14-d918db2f1f45",
"signal_type": "sec-8k",
"signal_subtype": "materialContract",
"detected_at": "2026-05-05T08:48:16.179+00:00",
"company": {
"name": "Quest Diagnostics",
"domain": "questdiagnostics.com"
},
"data": {
"detail": "Quest is securing $500M in fresh capital, indicating available budget for strategic initiatives beyond refinancing debt. The 'general corporate purposes' clause often precedes investments in technology, expansion, or M&A, creating opportunities for new vendor partnerships.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Public offering of senior notes for general corporate purposes and potential debt repayment",
"dollar_millions": 500
},
"summary": "Quest Diagnostics raises $500M in senior notes for debt repayment and general corporate purposes.",
"excerpts": "On April 27, 2026, Quest Diagnostics Incorporated (the “Company”) issued a press release announcing the pricing of a public offering of $500 million aggregate principal amount of its 5.000% senior notes due 2036 (the “Notes”)",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1022079/000110465926054141/tm2613096d1_8k.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"sales_relevance": "Vendor relationship signal",
"signal_category": "strategic",
"vendors_mentioned": [
"Goldman Sachs & Co. LLC",
"J.P. Morgan Securities LLC",
"Mizuho Securities USA LLC"
]
}
}
curl https://signals.autobound.ai/v1/signals/8cb83a60-6091-4f54-9f14-d918db2f1f45 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"questdiagnostics.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.